Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion

  • Authors:
    • Yuta Sato
    • Shin‑Ei Kudo
    • Katsuro Ichimasa
    • Shingo Matsudaira
    • Yuta Kouyama
    • Kazuki Kato
    • Toshiyuki Baba
    • Kunihiko Wakamura
    • Takemasa Hayashi
    • Toyoki Kudo
    • Noriyuki Ogata
    • Yuichi Mori
    • Masashi Misawa
    • Naoya Toyoshima
    • Tomoyuki Ishigaki
    • Yusuke Yagawa
    • Hiroki Nakamura
    • Tatsuya Sakurai
    • Yukiko Shakuo
    • Kenichi Suzuki
    • Yui Kudo
    • Shigeharu Hamatani
    • Fumio Ishida
    • Hideyuki Miyachi
  • View Affiliations

  • Published online on: September 28, 2018     https://doi.org/10.3892/ol.2018.9527
  • Pages: 7264-7270
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 16 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sato Y, Kudo SE, Ichimasa K, Matsudaira S, Kouyama Y, Kato K, Baba T, Wakamura K, Hayashi T, Kudo T, Kudo T, et al: Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion. Oncol Lett 16: 7264-7270, 2018.
APA
Sato, Y., Kudo, S., Ichimasa, K., Matsudaira, S., Kouyama, Y., Kato, K. ... Miyachi, H. (2018). Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion. Oncology Letters, 16, 7264-7270. https://doi.org/10.3892/ol.2018.9527
MLA
Sato, Y., Kudo, S., Ichimasa, K., Matsudaira, S., Kouyama, Y., Kato, K., Baba, T., Wakamura, K., Hayashi, T., Kudo, T., Ogata, N., Mori, Y., Misawa, M., Toyoshima, N., Ishigaki, T., Yagawa, Y., Nakamura, H., Sakurai, T., Shakuo, Y., Suzuki, K., Kudo, Y., Hamatani, S., Ishida, F., Miyachi, H."Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion". Oncology Letters 16.6 (2018): 7264-7270.
Chicago
Sato, Y., Kudo, S., Ichimasa, K., Matsudaira, S., Kouyama, Y., Kato, K., Baba, T., Wakamura, K., Hayashi, T., Kudo, T., Ogata, N., Mori, Y., Misawa, M., Toyoshima, N., Ishigaki, T., Yagawa, Y., Nakamura, H., Sakurai, T., Shakuo, Y., Suzuki, K., Kudo, Y., Hamatani, S., Ishida, F., Miyachi, H."Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion". Oncology Letters 16, no. 6 (2018): 7264-7270. https://doi.org/10.3892/ol.2018.9527